相关实验视频

Updated: Jun 13, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

CD19.CAR T细胞衍生的细胞外囊体表达CAR并杀死白血病细胞,有助于抗瘤疗法

Paola Lanuti^1,2, Francesco Guardalupi^1,2, Giulia Corradi³

¹Department of Medicine and Aging Sciences, University of Chieti-Pescara, Chieti, Italy.

|February 4, 2025

概括

化学抗原受体 (CAR) T细胞细胞外囊泡 (EVs) 显示出针对白血病的治疗潜力. 这些EV可以在患者中长期检测到,并且可以作为CAR T细胞治疗有效性的生物标志物.

科学领域:

免疫学免疫学免疫学
细胞生物学细胞生物学
生物技术是生物技术.

背景情况:

化学抗原受体 (CAR) T细胞疗法是一种有前途的癌症治疗方法.
目前正在研究CAR T细胞衍生的细胞外囊泡 (EVs) 的治疗应用.
了解EVs在CAR T细胞治疗中的作用和潜力至关重要.

研究的目的:

为了研究患者中CAR T细胞衍生的EVs的存在和功能.
评估EVs作为CAR T细胞治疗疗效的潜在生物标志物.
探索来自CAR T细胞的EV的治疗潜力.

主要方法:

在22名患者中监测循环的CD19 CAR+ T细胞衍生的EVs (CD19.CAR+EVs).
在细胞毒性作用方面分离和功能性表征CD19.CAR+EV.
开发符合良好制造实践 (GMP) 的电动汽车分离方法.

主要成果:

输注后CD19.CAR+EV可检测时间长达2年.
早期降低CD19.CAR+EV水平与治疗失败相关.
CD19.CAR+EVs对CD19+细胞表现出特定的细胞毒性作用,并携带了亲细胞的载荷.

结论:

CD19.CAR+EV是CAR-T细胞活动和治疗结果的有希望的生物标志物.
来自CAR T细胞的EV具有直接的抗白血病活性.
电动汽车是癌症治疗的潜在无细胞治疗产品.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on: March 14, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...